Severe Dermatitis Tied to Dupilumab-Associated Conjunctivitis Severe Dermatitis Tied to Dupilumab-Associated Conjunctivitis

Severe disease at baseline may be one of the factors associated with the development of conjunctivitis following treatment of atopic dermatitis with dupilumab, according to a small retrospective study.Reuters Health Information (Source: Medscape Allergy Headlines)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2wZ6qqy